A phase 1/2 study with satraplatin and simultaneous radiation in locally advanced non-small cell lung cancer.

Trial Profile

A phase 1/2 study with satraplatin and simultaneous radiation in locally advanced non-small cell lung cancer.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 19 Jul 2012

At a glance

  • Drugs Docetaxel; Satraplatin
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Agennix AG; GPC Biotech
  • Most Recent Events

    • 08 May 2012 Primary endpoints added as reported by Clinicaltrials.gov.
    • 08 May 2012 Investigational drug (Docetaxel) added as reported by Clinicaltrials.gov.
    • 21 Mar 2012 Actual patient number (20) adde as reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top